中美两国对国际人体受试者保护体系认证的认知差异

The Difference in Acknowledging the AAHRPP between China and America

在国家鼓励创新药研发的积极势态下,国内各临床试验机构更加重视提高人体医学研究过程中对受试者的保护,并积极遵循医学伦理实践的规范。只有从国际人体受试者保护体系认证整体及各个认证领域不同层面深入分析,清楚了解中美两国医院对国际人体受试者保护体系认证的认知差异,才能有的放矢,做好争取国际相关组织认证的准备工作。

With the active encouragement of the Chinese government, all domestic clinical research institutes pay more attention to the human research protect program （HRPP） during the process of clinical trials, and actively fol- low the regulations of medical ethical practice. We could make fully preparation for the accreditation by the correlated in- ternational organizations only by further analyzing the Association for Accreditation of Human Research Protection Pro- gram （AAHRPP） from a whole and in each accreditation field at different levels, thus having a clear understanding the difference in acknowledging the difference between China＇s hospitals and America＇s hospitals.